N.J. councilman fined for conflict of interest on housing project
Updated Apr 01, 2021;
A Bridgeton councilman has been fined for violating the state’s conflict-of-interest laws in relation to the sale of city land to a corporation to which had had a connection.
James Edwards was fined $100 on March 19 by the local finance board and has 30 days to appeal, documents show.
News of the fine was first reported by John Paff of Transparency NJ.
In 2017, Edwards voted “yes” on a resolution to sell parcels of land owned to a group that planned to build the RiverGrove housing project. Edwards served on the board of Tri-County Community Action Agency, one of the developers’ partners.
CT goes over 100,000 dose mark in vaccinations of long-term care residents, staff
Dave Altimari, CTMirror.org
FacebookTwitterEmail
1of3
Three vials of the Pfizer COVID-19 vaccine at Stamford Hospital, in Stamford, Conn. Dec. 17, 2020.Ned Gerard / Hearst Connecticut MediaShow MoreShow Less
2of3
A vile of te Pfizer-BioNTech vaccine is prepared on opening day of the Connecticut s largest COVID-19 Vaccination Drive-Through Clinic Monday, Jan. 18, 2021, in East Hartford, Conn.Jessica Hill / Associated PressShow MoreShow Less
3of3
More than 110,000 doses of COVID vaccine have been administered in the state’s long-term care facilities since late December, and state official estimate they are about two-thirds of the way to completing vaccinations of those residents.
New data show about two-thirds of long-term care residents and staff have been vaccinated for COVID ctmirror.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ctmirror.org Daily Mail and Mail on Sunday newspapers.
Share this article
SCOTTSDALE, Ariz., Feb. 3, 2021 /PRNewswire/ Matrix Medical Network
® (Matrix) today announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca s long-acting monoclonal antibody (LAAB) combination for the potential prevention of COVID-19. Matrix Clinical Solutions will meet eligible volunteers where they live and work with a fleet of Mobile Health Clinics and skilled clinicians, with a focus on populations more impacted by COVID-19.
Matrix Medical Network Mobile Health Clinic
Matrix is supporting the Phase III clinical trial called STORM CHASER, which will assess the safety and efficacy of AZD7442 for post-exposure prophylaxis in approximately 1,125 participants in the US and UK. Participants in this trial will include adults over 18 years of age following exposure to SARS-COV-2 and who are therefore at appreciable risk of developing COVID-19. The trial will include people liv
Tyson Foods : New Program Assesses, Verifies Effectiveness of Tyson Foods Covid-19 Risk Mitigation Efforts marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.